Cleared Traditional

K071984 - MODIFICATION TO CMA CEREBRAL TISSUE MONITORING SYSTEM

K071984 is an FDA 510(k) clearance for MODIFICATION TO CMA CEREBRAL TISSUE MON..., manufactured by Cma Microdialysis AB. The device is a Class 2 Neurology device with product code GWM cleared through the Traditional 510(k) pathway after a 344-day FDA review.

K071984 · Cma Microdialysis AB · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2008
Decision
344d
Days
Class 2
Risk

K071984 is an FDA 510(k) clearance for the MODIFICATION TO CMA CEREBRAL TISSUE MONITORING SYSTEM. Classified as Device, Monitoring, Intracranial Pressure (product code GWM), Class II - Special Controls.

Submitted by Cma Microdialysis AB (North Chelmsford, US). The FDA issued a Cleared decision on June 27, 2008 after a review of 344 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1620 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Cma Microdialysis AB devices

FDA 510(k) Submission Details - K071984

510(k) Number K071984 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 19, 2007
Decision Date June 27, 2008
Days to Decision 344 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
196d slower than avg
Panel avg: 148d · This submission: 344d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GWM Device Classification - Class 2, Special Controls

Product Code GWM Device, Monitoring, Intracranial Pressure
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1620
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWM Device, Monitoring, Intracranial Pressure

All 47
Devices cleared under the same product code (GWM) and FDA review panel - the closest regulatory comparables to K071984.
INTEGRA CAMINO FLEX VENTRICULAR INTRACRANIAL PRESSURE MONITORING KIT WITH FLEX ADAPTER
K133754 · Integra LifeSciences Corporation · Mar 2014
INTEGRA LICOX PTO2 MONITOR
K131184 · Integra Lifesciences Corp. · Aug 2013
CAMINO 110-4B OLM INTRACRANIAL PRESSURE MNITORING KIT
K102875 · Integra LifeSciences Corporation · Dec 2010
MODIFICATION TO NEUROSENSOR CEREBRAL BLOOD FLOW AND INTRACRANIAL PRESSURE MONITORING SYSTEM
K071505 · Integra LifeSciences Corporation · Aug 2007
INTEGRA MOBIUS MULTI-MODALITY MONITORING SYSTEM
K061640 · Integra LifeSciences Corporation · Jul 2006
LICOX IT2 COMPLETE BRAIN TUNNELING PROBE KIT
K053244 · Integra Lifesciences Corp. · May 2006